Discovery of an Orally Bioavailable Gonadotropin-Releasing Hormone Receptor Antagonist-Reference-Cited by-同舟云学术

Discovery of an Orally Bioavailable Gonadotropin-Releasing Hormone Receptor Antagonist

Published:2016-09-27 Issue:19 Volume:59 Page:9150-9172
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kim Seon-Mi¹,Lee Minhee¹,Lee So Young¹,Park Euisun²,Lee Soo-Min¹,Kim Eun Jeong¹,Han Min Young¹,Yoo Taekyung¹,Ann Jihyae³,Yoon Suyoung³,Lee Jiyoun⁴,Lee Jeewoo³

Affiliation:

1. Life Science R&D Center, SK Chemicals Company Ltd., Seongnam-si, Gyeonggi-do, 463-400, Korea

2. Life Science Research Center, Daewoong Pharmaceutical Company Ltd., Yongin-si, Gyeonggi-do, 449-814, Korea

3. Laboratory of Medicinal Chemistry, College of Pharmacy, Seoul National University, Seoul 151-742, Korea

4. Department of Global Medical Science, Sungshin University, Seoul 142-732, Korea

Funder

Ministry of Health and Welfare

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01071

Reference34 articles.

1. GnRHs and GnRH receptors

2. Intracellular Signaling Pathways Mediated by the Gonadotropin-Releasing Hormone (GnRH) Receptor

3. Clinical applications of GnRH and its analogues

4. The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers

5. Gonadotropin-Releasing Hormone Agonists in the Treatment of Prostate Cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022;Results in Chemistry;2024-01

2. Highly Selective 1,4-Diacylation/Cycloisomerization of 1,3-Enynes: De Novo Synthetic Strategy to Polysubstituted Furans;Organic Letters;2023-12-20

3. Research advances in drug therapy of endometriosis;Frontiers in Pharmacology;2023-06-21

4. Discovery of the thieno[2,3-d]pyrimidine-2,4-dione derivative 21a: A potent and orally bioavailable gonadotropin-releasing hormone receptor antagonist;European Journal of Medicinal Chemistry;2022-11

5. Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids;Expert Opinion on Drug Metabolism & Toxicology;2022-08-03